A Study of Positive Long-Term Functional Outcomes with Early Tracheostomy in Ventilated Stroke Patients

Overview

About this study

The purpose of this study is to test for the long-term outcomes in function for stroke patients who get an early tracheostomy, versus those who have prolonged orotracheal intubation. 

 

 

Patients with severe ischemic and hemorrhagic strokes, who require mechanical ventilation, have a particularly bad prognosis. If they require long-term ventilation, their orotracheal tube needs to be, like in any other intensive care patient, replaced by a shorter tracheal tube below the larynx. This so called tracheostomy might be associated with advantages such as less demand of narcotics and pain killers, less lesions in mouth and larynx, better mouth hygiene, safer airway, more patient comfort and earlier mobilisation. The best timepoint for tracheostomy in stroke, however, is not known. Preliminary data from a pilot study of early tracheostomy in patients with hemorrhagic or ischemic stroke suggest that such patients may also have improved survival and long-term functional outcomes, but a large, multicenter clinical trial is needed to confirm these findings.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria

  • Age 18 years or older
  • One of the following confirmed admission diagnoses
    • Non-traumatic acute ischemic infarction
    • Non-traumatic intracerebral hemorrhage
    • Non-traumatic subarachnoid hemorrhage
  • Informed consent from patient or legal representative
  • Estimated ventilation need for at least 2 weeks
  • The clinical judgement of the attending neurointensivist
  • Principle indication for tracheostomy at least one of the following
    • Ongoing demand of suctioning bronchotracheal secretions
    • CNS-related respiratory insufficiency
    • Aspiration or danger of aspiration due to dysphagia

Exclusion Criteria

  • Premorbid modified Rankin Score >1
  • Artificial ventilation for more than 4 days
  • Severe chronic pulmonary disease requiring supplemental oxygen, or evidence of CO2 retention on admission serum analysis (HCO3≥30)
  • Severe chronic cardiac disorder
  • Any emergency situation compromising the patient's well-being or ability to undergo tracheostomy in the study time-frame
    • Intracranial pressure (ICP) persistently > 25mmHg
    • Difficult airway management, anticipated problems with extubation / re-intubation
    • Contraindications for a percutaneous tracheostomy
    • Oxygenation impairment,  Positive end-expiratory pressure > 12, or fraction of inspired oxygen > 0.6
  • Need for a permanent surgical tracheostomy
  • Pregnancy
  • Participation in any other interventional trial
  • Life expectancy < 3 weeks
  • Patient/family unlikely to opt for at least 3 weeks of aggressive therapy prior to consideration of transition to comfort measures/discontinuation of life support measures

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

William Freeman, M.D.

Open for enrollment

Contact information:

Alexandra Kropnick

127or7833795

Kropnick.Alexandra@mayo.edu

More information

Publications

  • Optimal timing of tracheostomy in ventilated patients with severe stroke is unclear. We aimed to investigate feasibility, safety, and potential advantages of early tracheostomy in these intensive care unit (ICU) patients. Read More on PubMed

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20270761

Mayo Clinic Footer